Current query:

Article Text contains Michaels [delete]

Solutions: Organizing principles > Scientific Integrity [delete]

Subject contains Science [delete]

Contamination agent: Medical [delete]

Refine:

by Text Search

by Type

by Current issues

by Human health condition

by Contamination agent

by Exposure pathway

by Ecological effects

by Infrastructure

by Emerging science

by Coverage

by Publisher

by Reporter

by Date
1 to 22 of 22 items 
 
While all links worked when entries were posted to the database, different publishers have different policies about retaining articles and providing access to archived material. Thus some of the links, particularly older ones, may no longer be functional. For links no longer working, you may be able to gain paid access to text via the publisher's site.
UW linked to ghostwriting. As fears were growing about the link between hormone therapy and breast cancer, a drug company paid the University of Wisconsin to sponsor ghostwritten medical education articles that downplayed the risks, records obtained by the Journal Sentinel show. Milwaukee Journal Sentinel, Wisconsin. 16 August 2009.
Media coverage of drug studies lacking, study says. Journalists too often leave out information that might reflect bias in drug study results, and use brand names that might implicitly promote the drug in question, a new study concludes. Boston Globe, Massachusetts. 6 October 2008.
It's not the answers that are biased, it's the questions. One of the eyebrow-raising statistics about the bisphenol A studies is the stark divergence in results, depending on who funded them. This striking difference in studies isn't unique to BPA. Washington Post. Opinion, 15 July 2008. [related story] [Registration Required]
Tobacco funded Mass. researchers. The nation's largest cigarette maker has paid for scientific research at four Massachusetts universities since 2000, a practice that critics of the tobacco industry liken to the Mafia underwriting crime fighting. Boston Globe, Massachusetts. 31 March 2008.
A lethal cover up: Britain's worst water poisoning scandal. After two decades of stone-walling by the authorities, alarming facts about the Camelford water incident are beginning to emerge, and this week a coroner opened inquests into a possible cover-up. London Daily Mail, United Kingdom. 15 December 2007.
Warning: Known to cause severe health risks to laboratory animals, bisphenol A is in you. Investigative reporting finds that the federal government's assurances that bisphenol A is a safe chemical are based on outdated and incomplete government studies and science mostly funded by the chemical industry. Milwaukee Journal Sentinel, Wisconsin. 2 December 2007. [related stories]
Thalidomide film premiere revives compensation fight. Germany's pharmaceutical industry spent more than a year trying to ban the film, but last night a moving, controversial and widely acclaimed television drama about the tragedy suffered by thousands of children crippled by the drug thalidomide was finally broadcast to an audience of millions. London Independent, United Kingdom. 8 November 2007.
Critical reaction to research initiative. Dow Chemical and BASF, the world's two largest chemical companies, have separately agreed to fund groundbreaking academic research initiatives at two of the most prestigious U.S. universities. The partnerships are getting some faculty criticism. Chemical & Engineering News. 6 November 2007.
Science's worst enemy: corporate funding. The biggest threat to science has been quietly occurring under the radar. The threat is money—specifically, the decline of government support for science and the growing dominance of private spending over American research. Discover. 18 October 2007. [related story]
FDA's user-fee habit. For the past 15 years, pharmaceutical companies have poured $2 billion into a program that helps finance the US FDA Administration, allowing the FDA to become one of the world's fastest drug-approval agencies. Now that influx of money is under fire. Washington Post. 3 April 2007. [Registration Required]
Questions about DuPont unsettle town. Tennessee officials were surprised to learn that DuPont's paint plant in New Johnsonville produces dioxin... the fourth-largest producer in the US. Documents submitted to the state don't mention the carcinogen. Nashville Tennessean, Tennessee. 25 February 2007. [related story]
Study condemns FDA's handling of drug safety. A report from the National Academy of Sciences says that the US system for ensuring drug safety needs major changes, and consumers should be wary of newly approved drugs. New York Times. 23 September 2006. [Registration Required]
Mis-lead. Over 2 years of investigation reveals that agencies charged with overseeing the DC water system used flawed science to try to quiet public concerns about lead in drinking water. Environmental Science & Technology. 1 June 2006. [related stories]
Chromium wars, the sequel. The EPA has asked for documents that could lead it to investigate the chromium industry for withholding from the government a key study supporting a stricter standard for the potentially deadly metal. Forbes. 29 March 2006. [related stories]
Chromium evidence buried, report says. Scientists working for the chromium industry withheld data about the metal's health risks while the industry campaigned to block strict new limits on the cancer-causing chemical. Washington Post. 24 February 2006. [related stories] [Registration Required]
The Weinberg proposal. A scientific consulting firm says that it aids companies in trouble, but critics say that it manufactures uncertainty and undermines science. From its roots defending the tobacco industry, it now defends Teflon, bisphenol A and phthalates. Environmental Science & Technology. 22 February 2006. [related stories]
Fraud in science. How much scientific fraud is out there? Estimates vary widely, and actual fraud is difficult to detect by reviewers and editors alike. Environmental Science & Technology. Opinion, 15 February 2006.
Science experiment. Public health scientists say that two legal developments-- the Supreme Court's landmark Daubert decision and the passage of the 2001 Data Quality Act-- are being used by industry to defeat government regulation, no matter how strong or conclusive the scientific evidence. ABA Journal. 7 November 2005.
Doctors reportedly sold drug-study secrets. The chairman of a Senate committee overseeing the financial markets is urging regulators to investigate the findings of a Seattle Times report that medical researchers routinely accept money to reveal secrets about drug studies to Wall Street firms. Seattle Times, Washington. 9 August 2005.
Drug safety special: The safety catch The past year has seen a beleaguered Food and Drug Administration publicly denounced as unable to protect the US public. Yet top FDA officials say that the agency's performance remains strong. Nature. 1 April 2005. [related stories] [Subscription Required]
Is tobacco research turning over a new leaf? Advocates say the tobacco industry is now serious about improving the safety of its products. But critics, who cite the industry's efforts to manipulate science over the past 50 years, see nothing but the same old smoke and mirrors. Science. 7 January 2005. [related stories] [Subscription Required]
Tobacco industry research grants spur debate. Nearly four years ago, the University of California's Board of Regents smothered a controversy by barring the university from investing in tobacco, primarily due to health risks associated with smoking. San Francisco Chronicle, California. 27 December 2004. [related stories]
1 to 22 of 22 items